We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
-$242M
(-16%)
Cap. Flow
-$285M
Cap. Flow
% of AUM
-22.45%
Top 10 Holdings %
Top 10 Hldgs %
6.3%
Holding
1,671
New
346
Increased
361
Reduced
380
Closed
578
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prothena Corp
PRTA
|
+$7.16M |
| 2 |
Diodes
DIOD
|
+$5.72M |
| 3 |
Insight Enterprises
NSIT
|
+$5.71M |
| 4 |
TECD
Tech Data Corp
TECD
|
+$5.28M |
| 5 |
CPWR
COMPUWARE CORP
CPWR
|
+$5.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$7.01M |
| 2 |
Gentherm
THRM
|
+$6.87M |
| 3 |
ZLC
ZALE CORPORATION
ZLC
|
+$6.08M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
+$5.96M |
| 5 |
Take-Two Interactive
TTWO
|
+$5.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.59% |
| 2 | Technology | 14.48% |
| 3 | Industrials | 10.28% |
| 4 | Financials | 9.62% |
| 5 | Consumer Discretionary | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CASC
501
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $762K | 0.06% |
39,180
-20,826
| -35% | -$367K |
|
502
Lifetime Brands
LCUT
$199M
| $757K | 0.06% |
48,171
+30,221
| +168% | +$498K |
|
|
BBOX
503
DELISTED
Black Box Corp
BBOX
| $756K | 0.06% |
+32,250
| New | +$735K |
|
|
KCLI
504
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
| $755K | 0.06% |
16,590
-4,169
| -20% | -$181K |
|
|
NXZ
505
DELISTED
NUVEEN DIV ADV MUNI FD-2
NXZ
| $752K | 0.06% |
54,102
+18,625
| +52% | +$258K |
|
|
MTOR
506
DELISTED
MERITOR, Inc.
MTOR
| $747K | 0.06% |
57,308
+26,676
| +87% | +$351K |
|
|
SWS
507
DELISTED
SWS GROUP INC
SWS
| $747K | 0.06% |
102,594
-69,143
| -40% | -$512K |
|
|
KYE
508
DELISTED
Kayne Anderson Energy
KYE
| $746K | 0.06% |
+22,997
| New | +$673K |
|
509
Seacoast Banking Corp of Florida
SBCF
$3.26B
| $745K | 0.06% |
68,499
-41,430
| -38% | -$440K |
|
|
ORBK
510
DELISTED
Orbotech Ltd
ORBK
| $745K | 0.06% |
49,103
-11,172
| -19% | -$168K |
|
|
TSRO
511
DELISTED
TESARO, Inc.
TSRO
| $745K | 0.06% |
+23,955
| New | +$638K |
|
512
Goldgroup Mining Inc.
GORO
$151M
| $739K | 0.06% |
+145,965
| New | +$667K |
|
513
Gorman-Rupp
GRC
$2.16B
| $738K | 0.06% |
20,869
+8,546
| +69% | +$277K |
|
514
Scully Royalty
SRL
$76.7M
| $738K | 0.06% |
19,291
-4,933
| -20% | -$185K |
|
|
SGNT
515
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $738K | 0.06% |
28,531
+9,997
| +54% | +$222K |
|
516
AeroVironment
AVAV
$7.57B
| $733K | 0.06% |
23,040
-18,416
| -44% | -$624K |
|
517
Kulicke & Soffa
KLIC
$5.3B
| $733K | 0.06% |
51,433
-7,314
| -12% | -$100K |
|
|
FOLD
518
DELISTED
Amicus Therapeutics
FOLD
| $732K | 0.06% |
219,094
+88,218
| +67% | +$207K |
|
|
HRG
519
DELISTED
HRG Group, Inc.
HRG
| $728K | 0.06% |
+57,345
| New | +$688K |
|
|
BALT
520
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $724K | 0.06% |
121,010
-228,798
| -65% | -$1.44M |
|
521
CACI
CACI
$10.8B
| $719K | 0.06% |
+10,238
| New | +$727K |
|
522
Piper Sandler
PIPR
$5.14B
| $719K | 0.06% |
55,524
-191,892
| -78% | -$2.16M |
|
|
AWP
523
abrdn Global Premier Properties Fund
AWP
$377M
| $718K | 0.06% |
32,159
-4,428
| -12% | -$96.1K |
|
524
Healthcare Services Group
HCSG
$1.56B
| $717K | 0.06% |
+24,348
| New | +$719K |
|
525
Ironwood Pharmaceuticals
IRWD
$611M
| $713K | 0.06% |
+55,542
| New | +$604K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q2 2014 Portfolio in Review
As of Q2 2014, TFS Capital held 1,671 positions worth $1.27B, down 16% from $1.51B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
TFS Capital withdrew a net $285M in Q2 2014, closing 578 positions and reducing 380 holdings. Its most notable exit was ZALE CORPORATION, an estimated $6.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.
Against the trend, TFS Capital opened a new position in Tech Data Corp worth $5.32M.
- TFS Capital's largest Q2 2014 buy was Tech Data Corp: 85,151 shares worth $5.32M.
- TFS Capital added most to Prothena Corp in Q2 2014, an estimated $7.16M increase.
- TFS Capital's biggest Q2 2014 reduction was RF MICRO DEVICES INC, cutting an estimated $7.01M.
- TFS Capital fully exited ZALE CORPORATION in Q2 2014, selling an estimated $6.08M.
- TFS Capital's ten largest holdings make up 6.3% of its $1.27B portfolio in Q2 2014.
- TFS Capital opened 346 new positions and closed 578 in Q2 2014.
- TFS Capital's portfolio value fell 16% quarter-over-quarter to $1.27B.
Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.